MicroSintesis Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $16.4M

  • Investors
  • 3

MicroSintesis General Information

Description

Developer of a microbiome-derived peptide platform designed for non-antibiotic animal health. The company develops precision postbiotic products and bioactive peptide technologies that modulate bacterial behavior, enabling livestock and companion animal owners to reduce dysbiosis risk and support gut resilience during high-stress production windows.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 797 Victoria Road
  • Victoria, Prince Edward Island C0A 2G0
  • Canada
Primary Industry
Other Agriculture
Other Industries
Biotechnology
Corporate Office
  • 797 Victoria Road
  • Victoria, Prince Edward Island C0A 2G0
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MicroSintesis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 25-Jun-2019 $16.4M Completed Generating Revenue/Not Profitable
2. Accelerator/Incubator 08-Jan-2018 Completed Generating Revenue/Not Profitable
1. Grant 26-Sep-2017 $16K Completed Generating Revenue/Not Profitable
To view MicroSintesis’s complete valuation and funding history, request access »

MicroSintesis Patents

MicroSintesis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020299061-A1 Quorum-sensing inhibitors and/or postbiotic metabolites and related methods Inactive 02-Jul-2019
CA-3145739-A1 Quorum-sensing inhibitors and/or postbiotic metabolites and related methods Pending 02-Jul-2019
EP-3993819-A1 Quorum-sensing inhibitors and/or postbiotic metabolites and related methods Pending 02-Jul-2019
EP-3993819-A4 Quorum-sensing inhibitors and/or postbiotic metabolites and related methods Pending 02-Jul-2019
US-20220347257-A1 Quorum-sensing inhibitors and/or postbiotic metabolites and related methods Inactive 02-Jul-2019 A61K38/08
To view MicroSintesis’s complete patent history, request access »

MicroSintesis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MicroSintesis Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Northern Private Capital Growth/Expansion Minority
Emergence Incubator Accelerator/Incubator
Innovation PEI Sovereign Wealth Fund
To view MicroSintesis’s complete investors history, request access »

MicroSintesis FAQs

  • When was MicroSintesis founded?

    MicroSintesis was founded in 2011.

  • Where is MicroSintesis headquartered?

    MicroSintesis is headquartered in Victoria, Canada.

  • What is the size of MicroSintesis?

    MicroSintesis has 11 total employees.

  • What industry is MicroSintesis in?

    MicroSintesis’s primary industry is Other Agriculture.

  • Is MicroSintesis a private or public company?

    MicroSintesis is a Private company.

  • What is MicroSintesis’s current revenue?

    The current revenue for MicroSintesis is .

  • How much funding has MicroSintesis raised over time?

    MicroSintesis has raised $17.6M.

  • Who are MicroSintesis’s investors?

    Northern Private Capital, Emergence Incubator, and Innovation PEI have invested in MicroSintesis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process